Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity.

Ugurluer G., Atalar B., Zoto M., Gungor G., Aydin G., Sengoz M., ...More

The British journal of radiology, vol.94, no.1117, pp.20200696, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 94 Issue: 1117
  • Publication Date: 2021
  • Doi Number: 10.1259/bjr.20200696
  • Journal Name: The British journal of radiology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.20200696
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


Objective: Using moderate or ultra-hypofractionation, which is also known as stereotactic body radiotherapy (SBRT) for treatment of localized prostate cancer patients has been increased. We present our preliminary results on the clinical utilization of MRI-guided adaptive radiotherapy (MRgRT) for prostate cancer patients with the workflow, dosimetric parameters, toxicities and prostate-specific antigen (PSA) response.